Early research (Phase 1)Study completedNCT01841489
What this trial is testing
Novel GS-9973 Tablet Formulations to Evaluate the Effect of Acid Reducing Agents, Relative Bioavailability, and Food Effect on GS-9973 Pharmacokinetics
Who this might be right for
Chronic Lymphocytic Leukemia
Gilead Sciences 56